Rachael Moorin

Associate Professor

  • The University of Western Australia (M431), 35 Stirling Highway,

    6009 Perth

    Australia

  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Associate Professor Rachael Moorin is an adjunct Associate Professor in the School of Population and Global Health at the University of Western Australia and a Professor of Health Economics & Data Analytics at Curtin University in the School of Population Health.

Rachael completed a PhD in Population Health at UWA in 2005 and a Graduate Certificate in Health Economics from Curtin University also in 2005. She also has a Masters degree in Medical Radiation Science (Nuclear Medicine)

Roles and responsibilities

Rachael is an adjunct Associate Professor at the School of Population Health undertaking research in collaboration with the Centre for Health Services Research.

Rachael is a member of the Medical Services Advisory Committee (MSAC) and its evaluation sub-committee; Dept of Health and Ageing.

At Curtin University Rachael is Deputy Head of the Curtin School of Population Health.

Rachael has been responsible for developing novel methods for utilising and analysing linked administrative health data to promote evidence-based care; reduce ineffective, wasteful or harmful care; reduce unnecessary downstream health care use and costs; and improve health outcomes for patients with a range of chronic conditions. Rachael currently leads a team of four researchers at Curtin University where she is a member of the Curtin Institute for Computation Science and a founding member of the Health Economics Cluster and the Health Research and Data Analytics Hub.

Funding overview

2021: *Sim M, Law M, Brims F, Holland A, Wolfe R, Hoy R, Galban C, Abramson M, Barnes H [Moorin R: AI Leading the dosimetry analysis]: Emerging techniques for earlier diagnosis and assessment of severity and progression of artificial stone silicosis. MRFF. $994,642

2020: Ebert, Francis, Hung, Tang, Bydder, Perk, Schultz, Bellinge, Moorin, McCarthy, Campbell, Kasisi: Research Translation Project Grant. Molecular imaging for precision medicine: efficiency gains via automated annotation. 2020-21. $242,667

2020: *Saunders, Houssami, Mann, Spillane, Soon, Taylor, Bulsara, Reintals, Taylor, Moorin. Medical Research Future Fund Grant. Evaluation of clinical pathways and patient outcomes for breast MRI in preoperative assessment and staging of breast cancer: Establishing when MRI improves patient outcomes and when it does not: 2020-2022. $2,290,000.

2019: Moorin. WA Department of Health Merit Award. Quantifying the influence of aspects of continuity of primary care on quality and safety in the Australian health care system.: 2019-20. $75,000.

2019: *Toye, Hill, Moyle, Moorin, Hill, Slayter, Bryant, Waldron, Aoun Parsons. NHMRC Project Grant: Multicentre randomised controlled trial: caregiver, patient, and system outcomes from a program supporting informal caregivers of older people discharged home from hospital: 2019-2023. $1,500,380

2019: * Moore, Aoun, Stiberc, Hilbers, Cross, Rumbold, Moorin. MRFF: Rapid Applied Research Translations Grant. A community and health system partnership to prevent hospitalisation and improve outcomes through a Compassionate Communities Model of End of Life Care: 2019-2021. $250,000.

2018: Halkett, O’Connor, Ngune, Moorin, Youens.  Abbie Basson Sarcoma Foundation: Determining the unmet needs of patients diagnosed with sarcoma and the role of the Sarcoma Clinical Nurse Consultant: 2018-19. $70,174.

2018: *Moorin, Bulsara, Doust, Huxley, Fox, O’Leary, Slavotinek, McRobbie. NHMRC Project Grant: Monitoring changes in CT scanning usage to minimise cancer risk 2018-2020: $604,664.

2017: Moorin. WA Department of Health Merit Award. Monitoring changes in CT scanning usage to minimise cancer risk: 2017-18. $75,000.

2017: Taylor, Savaridas, Phillips, Moorin: Royal Australasian College of Radiologists (RANZCR): Can contrast enhanced spectral mammography play a clinically useful role in the pre-operative assessment of women with Ductal Carcinoma in Situ (DCIS), the ‘CESM D’ Study. 2017-18.: $30,000

2017: *Troller, Vajdic, Lennox, Moorin, Reppermund: NHMRC Project Grant: Understanding health service system needs for people with intellectual disability: 2017-2021: $1,216,389.

2016: *Halkett, Nowak, Lobb, Phillips, Hudson, Moorin, Shaw, Miller & Bulsara: Cancer Australia: 2015 Priority-driven Collaborative Cancer Research Scheme: Confidence to Care: A multi-state randomised controlled trial of structured nurse-led home-based support and education for carers of people with high grade glioma: 2016-2018: $535,789.

2016: Halkett, Nowak, Lobb, Phillips, Hudson, Moorin, Shaw, Miller & Bulsara: WA Cancer Council Project Grant: Confidence to Care: A multi-state randomised controlled trial of structured nurse-led home-based support and education for carers of people with high grade glioma. 2016: $97,000.

2015: Taylor, Saunders, Bourke & Moorin: Cancer Council Project Grant: Can ROLLIS (Radioguided Occult Lesion Localisation using Iodine 125 Seeds) Reduce Relative Re-excision Rates for impalpable breast cancer? The five "R"'s Randomised Clinical Trial. 2015-2016: $93,000.

2015: *Moorin, Preen, Hall, Harris, Hendrie, Bulsara, Vickery & Gibson: NHMRC Project Grant: Does continuity of primary care reduce demand on emergency department presentations and hospital admissions? 2015-2019: $793,864.

2015: Toye, Moorin, Slatyer, Aoun, Hill & Parsons: SHRAC Research translational project grant: Implementing an outreach support program for family carers of older people discharged from an acute medical assessment unit: Cost consequences for the Western Australian health care system. 2015-2016: $240,909.

2014: Moorin. WA Department of Health Merit Award. Does continuity of primary care reduce demand on emergency department presentations and hospital admissions? 2014-15. $75,00

2013: Halkett GKB, Nowak A, Lobb E, Agar M, Miller L, Moorin R, Shaw T. Cancer Council of WA:  Confidence to Care: A randomised controlled trial of structured home-based support and education for carers of people with high grade glioma. 2013: $99,315.

2012: Einarsdottir, Moorin, Hung, Preen, Sanfilippo, Briffa: Heart Foundation Grant-In-Aid: The Impact of Federal Health Care Policy on Coronary Artery Revascularisation Procedure Outcomes from 1988-2008. 2012-2013: $130,000.

2011: *Moorin, Holman, Bulsara & Fox:  NHMRC Project grant: Policy translation of an Australian evaluation of computed tomography (CT) scanning. 2011-2013: $386,000.

2010: Murray, Keed, Riley, Moorin: SHRAC Research translational project grant: Epidemiology of Clostridium difficile in patients receiving outpatient intravenous antibiotic therapy. 2010-2011: $86,000.

2010: *Holman, Emery, Saunders, Walter, Moorin, Auret, Preen, Bulsara:  NHMRC Partnership project grant: Partnership Intervention Trial to Redress Treatment Delay and Improve Outcomes in Rural Cancer Patients. 2010-2014: $2.2M.

2009: *Jorm, Roberts, Preen, Simpson, Moorin, Haines, Bambrick, Holman:  NHMRC Capacity Building Grant in Population Health & Health Services Research: OSPREY: Building capacity for research to improve health services for mothers, babies and children. 2009 – 2013: $2.4M.

2009: Emery, Holman, Saunders, Fritschi, Auret, Nowak, Monterosso, Preen, Moorin, Vaz, Walter, Booth, Mears, Kirke, Willix and Jeffries-Stokes:  Crawford Rural Cancer Research Initiative (CCWA): Cancer Treatment Quality and Delay: Development of a Complex Intervention to Improve Rural Cancer Outcomes. 2009 -2010: $300,000.

2007: Moorin, Turner & Meyrick: The inaugural Research Grant Award from the Australian and New Zealand Society of Nuclear Medicine: Reducing the Renal Radiation Burden during Radiopeptide Therapy using Metal Chelating Agents. 2007: $10,000.

2007: Moorin & Heyworth: UWA small grants scheme; Estimating the hospital costs of the sequelae of gastroenteritis in Western Australia. 2007: $25,000.

2004: Moorin & Turner: Fremantle Hospital Medical Research Grant 2004: Pre-Clinical Evaluation of 2,3 Dimercaptosuccinic acid (DMSA) as a radiation nephrotoxicity protective agent during radio-peptide therapy of neuroendocrine tumours. 2004: $15,000.

Research

Since completing her PhD in 2005, Prof Moorin has been awarded competitive research grants as chief investigator totalling more than $18 million from State and national funding agencies, ~12 million of which has been awarded since moving from substantial teaching/leadership roles into full-time research in mid-2011.

Prof Moorin has been a CI on seven NHMRC-funded studies totalling $12 million, three as CIA. In addition, she has been a CI on seven other National/State competitively funded projects including Cancer Australia and the Heart Foundation. She has also been awarded substantial industry funding (e.g. CIA Insurance Commission of WA ($200,000); CIB on two WA Primary Health Alliance translation projects ($2.6 and $1.2 million, respectively) and CIB on WA Dept of Health Statistical Support for Patient Safety and Quality.

Prof Moorin is a past Director of the UWA node of the Australian Centre for Economic Research on Health (2007-10) and a past director (2011-12 term) and current executive committee member (2019-22 term) of the International Population Data Linkage Network, which is the international body representing the academic activity of data scientists using population level data. Her leadership and expertise in this field is evidenced by her recent international collaboration to publish “A Position Statement on Population Data Science” (International Journal for Population Data Science. 2018 Feb: 3:4).

 

Fingerprint

Dive into the research topics where Rachael Moorin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or